These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15363481)

  • 1. Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment.
    Poulet E; Brunelin J; Boeuve C; Lerond J; D'Amato T; Dalery J; Saoud M
    Eur Psychiatry; 2004 Sep; 19(6):382-3. PubMed ID: 15363481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients.
    Mosimann UP; Schmitt W; Greenberg BD; Kosel M; Müri RM; Berkhoff M; Hess CW; Fisch HU; Schlaepfer TE
    Psychiatry Res; 2004 Apr; 126(2):123-33. PubMed ID: 15123391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder.
    Wang YM; Li N; Yang LL; Song M; Shi L; Chen WH; Li SX; Wang XY; Lu L
    Psychiatry Res; 2017 Aug; 254():18-23. PubMed ID: 28441583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive transcranial magnetic stimulation as add-on antidepressant treatment. The applicability of the method in a clinical setting.
    Hansen PE; Videbech P; Clemmensen K; Sturlason R; Jensen HM; Vestergaard P
    Nord J Psychiatry; 2004; 58(6):455-7. PubMed ID: 16195088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    J Clin Psychiatry; 2013 Feb; 74(2):e122-9. PubMed ID: 23473357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study.
    Prasko J; Pasková B; Záleský R; Novák T; Kopecek M; Bares M; Horácek J
    Neuro Endocrinol Lett; 2006 Jun; 27(3):327-32. PubMed ID: 16816829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-term results of combined treatment with transcranial magnetic stimulation and antidepressant drug for chronic tinnitus.
    Bilici S; Yigit O; Taskin U; Gor AP; Yilmaz ED
    Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):337-43. PubMed ID: 24337899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials.
    Kedzior KK; Reitz SK; Azorina V; Loo C
    Depress Anxiety; 2015 Mar; 32(3):193-203. PubMed ID: 25683231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis.
    Brunoni AR; Lopes M; Kaptchuk TJ; Fregni F
    PLoS One; 2009; 4(3):e4824. PubMed ID: 19293925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression.
    Paus T; Barrett J
    J Psychiatry Neurosci; 2004 Jul; 29(4):268-79. PubMed ID: 15309043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The concept of resistant depression and therapeutic strategies, particularly, with venlafaxine].
    Poirier MF
    Encephale; 1999 Jun; 25 Spec No 2():55-7; discussion 58-61. PubMed ID: 10434160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial.
    Mi Z; Biswas K; Fairchild JK; Davis-Karim A; Phibbs CS; Forman SD; Thase M; Georgette G; Beale T; Pittman D; McNerney MW; Rosen A; Huang GD; George M; Noda A; Yesavage JA
    Trials; 2017 Sep; 18(1):409. PubMed ID: 28865495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.